How many stocks are there of Chromadex?
The current number of stocks of Chromadex is 74.99 M undefined.
Chromadex Stocks 2024
Chromadex Stocks
74.99 M
Chromadex Dividend yield
Ticker
CDXC
ISIN
US1710774076
WKN
A2AG5N
In 2024, Chromadex had 74.99 M outstanding stocks, a 0% change from the 74.99 M stocks in the previous year.
The Chromadex Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 74.99 |
| 2025e | 74.99 |
| 2024e | 74.99 |
| 2023 | 74.99 |
| 2022 | 69.73 |
| 2021 | 67.19 |
| 2020 | 61.07 |
| 2019 | 57.06 |
| 2018 | 55.01 |
| 2017 | 44.6 |
| 2016 | 37.29 |
| 2015 | 35.88 |
| 2014 | 35.49 |
| 2013 | 33.33 |
| 2012 | 30.09 |
| 2011 | 22.77 |
| 2010 | 16.08 |
| 2009 | 9.61 |
| 2008 | 9.44 |
| 2007 | 8.84 |
| 2006 | 0.46 |
Chromadex Aktienanalyse
What does Chromadex do?
The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Chromadex's Shares Outstanding
Chromadex's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Chromadex’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Chromadex’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Chromadex’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Chromadex Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Chromadex are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Chromadex evolved in recent years?
The number of shares of Chromadex has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Chromadex as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Chromadex?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Chromadex pay?
Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.
What is the dividend yield of Chromadex?
The current dividend yield of Chromadex is .
When does Chromadex pay dividends?
Chromadex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chromadex?
Chromadex paid dividends every year for the past 0 years.
What is the dividend of Chromadex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chromadex located?
Chromadex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chromadex from 4/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/20/2024.
When did Chromadex pay the last dividend?
The last dividend was paid out on 4/20/2024.
What was the dividend of Chromadex in the year 2023?
In the year 2023, Chromadex distributed 0 USD as dividends.
In which currency does Chromadex pay out the dividend?
The dividends of Chromadex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Chromadex stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Chromadex
Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
